International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 118

Iraq | Pediatrics | Volume 8 Issue 5, May 2019 | Pages: 1317 - 1320


Random Use of Recombinant Activated Factor VII in Pediatric Age Groups

Aisha. M. Al-Doroobi, Hayat. H. Obayid, Khalid. B-Kago

Abstract: Bleeding disorders in pediatrics is an important issue and can be life threatening if not diagnosed and treated appropriately. Infants and their families who are affected by these illnesses have poor life quality and often dysfunctional. In this study, we focused on bleeding disorders that have high prevalence in infants and children and are often over looked in other trials and studies where most of their focus was dedicated towards using factor VII in pre-andpost-operative hemorrhages and trauma. We involved 35 patients with various bleedings disorders whom were treated with recombinant factor VII with follow-up over the course of six months. The drug proved its effectiveness with success rate as high as 91.4 % and mortality rate of 8.5 %.

Keywords: Recombinant, Factor VII, Bleeding disorders, Hemorrhage, pediatrics, Hematemesis



Citation copied to Clipboard!

Rate this Article

5

Characters: 0

Received Comments

No approved comments available.

Rating submitted successfully!


Top